Dr Xanthe Strudwick is a Research Associate within the Regenerative Medicine Laboratories of the Future Industries Institute whose research is aimed at developing novel therapeutics for wound repair, reducing scar formation and understanding the mechanisms involved in tissue regeneration. Xanthe began her research into skin biology with Professor Cowin’s laboratory at the Women’s and Children’s Health Research Institute before the lab's move to UniSA. Xanthe was awarded her PhD from UniSA for her investigation of the role of the cytoskeletal protein Flightless I in tissue regeneration. Her current research is aimed at the development of a novel antibody based therapy to reduce... Read more
About me
Dr Xanthe Strudwick is a Research Associate within the Regenerative Medicine Laboratories of the Future Industries Institute whose research is aimed at developing novel therapeutics for wound repair, reducing scar formation and understanding the mechanisms involved in tissue regeneration. Xanthe began her research into skin biology with Professor Cowin’s laboratory at the Women’s and Children’s Health Research Institute before the lab's move to UniSA. Xanthe was awarded her PhD from UniSA for her investigation of the role of the cytoskeletal protein Flightless I in tissue regeneration. Her current research is aimed at the development of a novel antibody based therapy to reduce inflammation and prevent scar formation in burn wounds. Xanthe is also working with materials scientists and physical chemists to develop novel wound dressings and investigate the use of low-temperature, atmospheric-pressure plasmas for biological and medical applications.
About me
Doctor of Philosophy University of South Australia
Bachelor of Health Science (Honours) (Medical and Pharmaceutical Biotechnology) University of South Australia
Research
Excludes commercial-in-confidence projects.
Plasma activated hydrogel therapy for combatting antimicrobial resistance in chronic wounds, NHMRC - Ideas Grants, 01/01/2021 - 31/12/2023
Research
Research outputs for the last seven years are shown below. To see earlier years visit ORCID, ResearcherID or Scopus
Open access indicates that an output is open access.
| Year | Output |
|---|---|
| 2018 |
Open access
1
|
| Year | Output |
|---|---|
| 2023 |
|
| 2023 |
Open access
|
| 2022 |
2
2
5
|
| 2022 |
Open access
2
2
|
| 2021 |
Open access
18
|
| 2021 |
Open access
37
33
38
|
| 2021 |
Open access
4
4
2
|
| 2021 |
Open access
|
| 2020 |
Open access
12
12
22
|
| 2020 |
Open access
9
9
5
|
| 2020 |
Open access
11
12
|
| 2020 |
Open access
10
10
1
|
| 2020 |
Open access
10
9
6
|
| 2020 |
Open access
7
9
1
|
| 2018 |
1
|
| 2018 |
Open access
1
|
| 2017 |
Open access
7
7
6
|
| 2016 |
Open access
25
25
2
|
| 2015 |
7
7
|
| 2015 |
Open access
30
28
9
|
| 2012 |
Open access
6
|
| 2011 |
Open access
33
34
|
| 2009 |
39
40
|
| 2009 |
37
34
|
| 2008 |
Open access
27
27
|
External engagement & recognition
| Organisation | Country |
|---|---|
| Athersys Inc | UNITED STATES |
| Athersys, Inc. | UNITED STATES |
| Australian National University | AUSTRALIA |
| John Curtin School of Medical Research | AUSTRALIA |
| Kochi Medical School | JAPAN |
| Kochi University of Technology | JAPAN |
| Lancaster University | UNITED KINGDOM |
| Meijo University | JAPAN |
| Queensland University of Technology | AUSTRALIA |
| ReGenesys | SOUTH AFRICA |
| Royal Adelaide Hospital | AUSTRALIA |
| Toyo University | JAPAN |
| University of Adelaide | AUSTRALIA |
| University of California | UNITED STATES |
| University of Freiburg | GERMANY |
| University of Liverpool | UNITED KINGDOM |
| University of Lubeck | GERMANY |
| University of New South Wales | AUSTRALIA |
| University of South Australia | AUSTRALIA |
| Women's & Children's Health Research Institute Inc | AUSTRALIA |
| Women's and Children's Health Network | AUSTRALIA |
Teaching & student supervision
Supervisions from 2010 shown
| Thesis title | Student status |
|---|---|
| Developing a systemic monoclonal antibody therapy for the treatment of large burn injuries | Current |
| Development of new approaches for the treatment of infected wounds | Current |
| Graphene-metal oxide hybrid deposited on the flexible substrate for wearable, non-enzymatic and non-invasive glucose biosensor | Current |
